Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Autolus Therapeutics (AUTL) Profit After Tax: 2016-2024

Historic Profit After Tax for Autolus Therapeutics (AUTL) over the last 9 years, with Dec 2024 value amounting to -$220.7 million.

  • Autolus Therapeutics' Profit After Tax rose 3.63% to -$79.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$224.8 million, marking a year-over-year increase of 16.81%. This contributed to the annual value of -$220.7 million for FY2024, which is 5.90% down from last year.
  • As of FY2024, Autolus Therapeutics' Profit After Tax stood at -$220.7 million, which was down 5.90% from -$208.4 million recorded in FY2023.
  • Autolus Therapeutics' Profit After Tax's 5-year high stood at -$142.1 million during FY2021, with a 5-year trough of -$220.7 million in FY2024.
  • Over the past 3 years, Autolus Therapeutics' median Profit After Tax value was -$208.4 million (recorded in 2023), while the average stood at -$192.6 million.
  • Per our database at Business Quant, Autolus Therapeutics' Profit After Tax climbed by 0.00% in 2021 and then slumped by 40.02% in 2023.
  • Autolus Therapeutics' Profit After Tax (Yearly) stood at -$142.1 million in 2020, then climbed by 0.00% to -$142.1 million in 2021, then dropped by 4.75% to -$148.8 million in 2022, then slumped by 40.02% to -$208.4 million in 2023, then fell by 5.90% to -$220.7 million in 2024.